Related Experiment Videos
Patient satisfaction with antihypertensive therapy.
K Chen1, C-F Chiou, C A Plauschinat
1Cerner Health Insights, Beverly Hills, CA, USA.
Journal of Human Hypertension
|June 14, 2005
Summary
Patient satisfaction with hypertension treatment increases with controlled blood pressure and fewer adverse events. Angiotensin receptor blockers (ARBs) showed the lowest adverse event rates.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Patient-Reported Outcomes
Background:
- Hypertension management requires effective and satisfactory patient treatment.
- Patient satisfaction is a key factor in adherence to antihypertensive therapy.
- Understanding factors influencing satisfaction is crucial for optimizing treatment outcomes.
Purpose of the Study:
- To assess factors associated with treatment satisfaction in patients on antihypertensive therapy.
- To compare satisfaction levels across different classes of antihypertensive medications.
- To identify the impact of blood pressure control and adverse events on patient satisfaction.
Main Methods:
- A weighted cross-sectional online survey of hypertensive patients in the US.
- Inclusion of patients on monotherapy: ACE inhibitors (ACEIs), ARBs, beta blockers (BBs), calcium channel blockers (CCBs), and diuretics.
- Pairwise comparisons between treatment groups and a control group (no treatment).
Main Results:
- Patients with controlled blood pressure (BP) showed higher satisfaction (90.3%) than those with uncontrolled BP (71.5%).
- Patients without adverse events reported higher satisfaction (90.9%) versus those with adverse events (75.8%).
- Angiotensin receptor blockers (ARBs) had the lowest adverse event rates, and patients on ARBs were most likely to have switched therapies.
Conclusions:
- Achieving blood pressure control is vital for improving patient satisfaction with antihypertensive therapy.
- Minimizing adverse events, such as frequent urination, sexual dysfunction, and fatigue, is essential for enhancing treatment satisfaction.
- Angiotensin receptor blockers (ARBs) may offer a favorable profile regarding adverse events and patient satisfaction.